Literature DB >> 22647065

The role of long-range intermolecular interactions in discovery of new drugs.

Nevena Veljkovic1, Sanja Glisic, Vladimir Perovic, Veljko Veljkovic.   

Abstract

INTRODUCTION: Long-range intermolecular interactions (interactions at distances between 100 and 1000 Å) play an important role in the interaction between drugs and therapeutic targets, and design techniques based on this concept could significantly improve and accelerate new drug discovery. Understanding these long-range intermolecular interactions will also help further our understanding of the molecular mechanisms and the underlying basic biological processes. AREAS COVERED: This article looks at the physical bases of long-range intermolecular interactions in biological systems with a brief review of the literature data to support this concept. The article also gives some examples of techniques used in drug discovery that were based on the long-range intermolecular interaction concept. EXPERT OPINION: The electron-ion interaction potential (EIIP) and average quasivalence number (AQVN) concepts shed new light on the role of long-range intermolecular interactions in biological systems. Further research of physicochemical mechanisms underlying long-range interactions between biological molecules is necessary for a better understanding of the basic biological processes. The addition of the computer-aided design techniques based on the EIIP/AQVN concept to the research and development will lead not only to a significant reduction in cost but also to an acceleration in the development of new drugs.

Year:  2011        PMID: 22647065     DOI: 10.1517/17460441.2012.638280

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  11 in total

1.  In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's Disease.

Authors:  Tijana Bojić; Milan Sencanski; Vladimir Perovic; Jelena Milicevic; Sanja Glisic
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

2.  In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.

Authors:  Veljko Veljkovic; Marco Goeijenbier; Sanja Glisic; Nevena Veljkovic; Vladimir R Perovic; Milan Sencanski; Donald R Branch; Slobodan Paessler
Journal:  F1000Res       Date:  2015-05-01

3.  Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.

Authors:  Veljko Veljkovic; Philippe M Loiseau; Bruno Figadere; Sanja Glisic; Nevena Veljkovic; Vladimir R Perovic; David P Cavanaugh; Donald R Branch
Journal:  F1000Res       Date:  2015-02-02

4.  Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus.

Authors:  Tijana Bojić; Vladimir R Perović; Milan Senćanski; Sanja Glišić
Journal:  Front Neurosci       Date:  2017-11-14       Impact factor: 4.677

5.  A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet.

Authors:  Veljko Veljkovic; Vladimir Perovic; Marko Anderluh; Slobodan Paessler; Milena Veljkovic; Sanja Glisic; Garth Nicolson
Journal:  F1000Res       Date:  2017-01-05

6.  Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.

Authors:  Draginja Radosevic; Milan Sencanski; Vladimir Perovic; Nevena Veljkovic; Jelena Prljic; Veljko Veljkovic; Emily Mantlo; Natalya Bukreyeva; Slobodan Paessler; Sanja Glisic
Journal:  Front Cell Infect Microbiol       Date:  2019-03-26       Impact factor: 5.293

7.  Experimental evidence for long-distance electrodynamic intermolecular forces.

Authors:  Mathias Lechelon; Yoann Meriguet; Matteo Gori; Sandra Ruffenach; Ilaria Nardecchia; Elena Floriani; Dominique Coquillat; Frédéric Teppe; Sébastien Mailfert; Didier Marguet; Pierre Ferrier; Luca Varani; James Sturgis; Jeremie Torres; Marco Pettini
Journal:  Sci Adv       Date:  2022-02-16       Impact factor: 14.136

8.  In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.

Authors:  Tijana Bojić; Vladimir R Perović; Sanja Glišić
Journal:  Front Neurosci       Date:  2016-01-21       Impact factor: 4.677

9.  Editorial: Neurocardiovascular Diseases: New Aspects of the Old Issues.

Authors:  Tijana Bojić
Journal:  Front Neurosci       Date:  2019-01-11       Impact factor: 4.677

10.  Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β2-adrenergic receptor (β2-AR).

Authors:  Milan Sencanski; Sanja Glisic; Marko Šnajder; Nevena Veljkovic; Nataša Poklar Ulrih; Janez Mavri; Milka Vrecl
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.